Share on StockTwits

PerkinElmer (NYSE:PKI) SVP Daniel R. Marshak sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 26th. The stock was sold at an average price of $46.60, for a total transaction of $466,000.00. Following the transaction, the senior vice president now directly owns 45,445 shares of the company’s stock, valued at approximately $2,117,737. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of PerkinElmer (NYSE:PKI) traded up 0.09% during mid-day trading on Friday, hitting $46.79. The stock had a trading volume of 684,351 shares. PerkinElmer has a 52-week low of $32.22 and a 52-week high of $47.64. The stock’s 50-day moving average is $45.39 and its 200-day moving average is $43.87. The company has a market cap of $5.298 billion and a price-to-earnings ratio of 31.29.

PerkinElmer (NYSE:PKI) last announced its earnings results on Thursday, April 24th. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.44 by $0.02. The company had revenue of $531.90 million for the quarter, compared to the consensus estimate of $531.31 million. During the same quarter last year, the company posted $0.36 earnings per share. PerkinElmer’s revenue was up 5.2% compared to the same quarter last year. Analysts expect that PerkinElmer will post $2.46 EPS for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Wedbush raised their price target on shares of PerkinElmer from $47.00 to $52.00 in a research note on Wednesday, June 4th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of PerkinElmer in a research note on Wednesday, May 14th. They now have a $47.00 price target on the stock. Finally, analysts at Janney Montgomery Scott upgraded shares of PerkinElmer from a “neutral” rating to a “buy” rating in a research note on Monday, May 5th. They now have a $50.00 price target on the stock, up previously from $49.00. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $47.17.

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.